Abstract
The conduction properties of the atrioventricular (AV) node have a significant impact on the heart rate during persistent atrial fibrillation (AF) and can be modulated using β-blockers or calcium channel blockers. These drugs have different physiological effects and are often selected empirically. Hence, an improved understanding of how these drugs affect the AV node conduction properties may contribute to personalized treatment of AF.